Lebanon’s recent financial crisis has caused a dollar shortage that, since September, has restricted the ability of medical supply importers to import vital medical supplies. First it started with masks, gloves, and other protective gear, as well as ventilators and spare parts, and now even essential diabetes supplies are sometimes unavailable. Read more
When I left the hospital I remember wondering, “Why did my mom have to beg those people to do their job when I was visibly sick?” A few years later after I had dealt with numerous visits, checkups, and insurance calls, I became aware of the medical side of racism. Read more
In March of this year, researchers at the University of Pittsburgh provided evidence that the net price of insulin medicines in the United States had also soared – by 51% between 2008-2017. This indicates that while other intermediaries had benefited from list price increases, the manufacturers had too. This may seem obvious, but having data to prove it is important. Read more
Ten people living with type 1 diabetes share their perspectives about the impact of the coronavirus on their country and their health. Read more
This movement’s objective is to influence public policies for the benefit of people living with T1D in this country. We need your help. We need to learn from diabetes advocates in other countries and from their experience to change the lives of others and learn tools to raise our voice to make change happen. We believe that we can be stronger together. Read more
Having type 2 diabetes comes with a lot of misconceptions. People think that the disease always comes down to "lifestyle choices" like overeating sugar, or being obese. But for a person like me, genetics plays a factor. For others, insulin resistance is an inevitability. People living with type 2 diabetes are often told they've done it to themselves, and take on a lot of misplaced blame for an illness we didn't ask for -- that no one asks for.
Read more
The goal of T1International, despite being an organization predominantly advocating for patients with type 1 diabetes and having “T1” in its name, is to help all people with diabetes gain access to the medication and supplies they need to survive. When it comes down to it, does it really matter which type of diabetes one lives with? Are those without type 1 diabetes less worthy of help? Read more
On the 8th of January, members of Diabète et Méchant, the French Chapter of T1International, demonstrated in front of Sanofi’s headquartered in Paris against their insulin price policy. The demonstration was meant to commemorate the 98th anniversary of the first successful injection of insulin in 1922. Read more
We have had a truly incredible year. Unprecedented growth is the only way to put it. The global insulin crisis continues, but the momentum to counter this crisis is growing, thanks to patients around the world standing up and fighting for their right to health. Below, we share a summary of our highlights and biggest achievements, thanks to your donations, your advocacy, and your dedication to ensuring #insulin4all becomes a reality. Read more
As a diabetes community, we knew we had to do something. I reached out to T1International and we had a discussion, with ideas and feedback about how to advocate for the insulin needs of people with type 1 diabetes in Indonesia. I took part in a one-on-one Advocacy Training with T1International where I created a plan to resolve the limitation problem. Read more